Received: from CO6PR06MB7490.namprd06.prod.outlook.com (2603:10b6:303:a9::23) by BLAPR06MB6834.namprd06.prod.outlook.com with HTTPS; Fri, 26 Sep 2025 00:23:00 +0000 ARC-Seal: i=2; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=pass; b=P8cgFC4at4IwOUYyrpN4uYWL+FmBWi8Pc40+bENCPfCfHEa1xS8k61sRCpUoa5Yi4zh18v4EEyJZOHNvixhSmn3ojuUgNklXAd+wUwPOqp7jh++tuBWs1/hGbB92RLcxNWAsKbE/JmXOBU522iaSWseSdaMO6JEPvj4NZU55kgabxP1geVn7RyhV95hgjdA14wWmg0ZelyxWe7V4bwf4h61kXD4aZuur2Oh8LWQAtcMRRvbH77wi+KRk+DCdt6vCls6KH5/EAmnZRUKBvdUCZzigsOPbDlwt0GiOA0es67ERgat1H68zHwgUtscvJXD8FEwJ+4NQ7Z7Q2DJqoUQCEg== ARC-Message-Signature: i=2; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=M5upPG1SJA0MYxAUc5XGku17kacuWiavQqqMhZaQt+I=; b=CxS6kCYFEDRaXkxbx9tGNR/Z6yVx65nbHNMMNafoeQnDsRne4wFWqWYVCPLFjxwxJO/jEtTUJLUx54FQIyF8T6gcR/17nhnaMz8W5AtujXymerjt7NZhfnkBvcPCci122UM1jBRkL9rz6Yu8pFY8BMpw87dC+mAlxhtqEhdvp7qmcQsg+6t3a1ZpR4akPifnIlmNytuc4yGvOeEYYjOU52HOe0rh/xVX8ry4EplGqHjHYCpKPUs8xPdrrlRjeI2QnHZA43IGWSXJbeqjP55lrRgk2bJcnTybwDcLpj9nnaU1rBrHTb/mOmWKbM8isD0OC7bl8gkiO5K83Q6IPJzaMw== ARC-Authentication-Results: i=2; mx.microsoft.com 1; spf=pass (sender ip is 2a01:111:f403:c201::3) smtp.rcpttodomain=designerliving.com smtp.mailfrom=saudades.at; dmarc=bestguesspass action=none header.from=saudades.at; dkim=none (message not signed); arc=pass (0 oda=0 ltdi=1) Received: from SN7PR04CA0162.namprd04.prod.outlook.com (2603:10b6:806:125::17) by CO6PR06MB7490.namprd06.prod.outlook.com (2603:10b6:303:a9::23) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9160.11; Fri, 26 Sep 2025 00:20:54 +0000 Received: from SA2PEPF00003F66.namprd04.prod.outlook.com (2603:10b6:806:125:cafe::41) by SN7PR04CA0162.outlook.office365.com (2603:10b6:806:125::17) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9160.11 via Frontend Transport; Fri, 26 Sep 2025 00:20:54 +0000 Authentication-Results: spf=pass (sender IP is 2a01:111:f403:c201::3) smtp.mailfrom=saudades.at; dkim=none (message not signed) header.d=none;dmarc=bestguesspass action=none header.from=saudades.at;compauth=pass reason=109 Received-SPF: Pass (protection.outlook.com: domain of saudades.at designates 2a01:111:f403:c201::3 as permitted sender) receiver=protection.outlook.com; client-ip=2a01:111:f403:c201::3; helo=AS8PR04CU009.outbound.protection.outlook.com; pr=C Received: from AS8PR04CU009.outbound.protection.outlook.com (2a01:111:f403:c201::3) by SA2PEPF00003F66.mail.protection.outlook.com (2603:10b6:80f:fc04::29) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9160.9 via Frontend Transport; Fri, 26 Sep 2025 00:20:53 +0000 ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none; b=NRXNV+B+9yH1FQ3OVlsgMQZlvLFZKdtMBXHPWYom4qnRDolwjATriptTzMqWrWn/zSAGBlICE/x2QZ7NRPmaTeGXOOF1RxifZD6ASPO8lXhfcXIhf9isnLvZlzRQ+e3yhjME8YrahmLYtWkEzQTtJnRWoFDqw9Ub3pd1jDNdMjLIkANgFQ8pBiZcVLgPq9oJMd8ZRfUErvmUpyLgybwxfTzOInAFenWMeI04otQemgbkjRZJ5W6hZFrCobxBp6EDBEaw/Ehf3i1sbbknJWUixeGfj4eseq3sXQ8CbD0XZhE+jipBQn7TE70nK1L4byZLxuJnWn6o0uuV4po271Ml6A== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=M5upPG1SJA0MYxAUc5XGku17kacuWiavQqqMhZaQt+I=; b=W1xpiJyosAIynH3W6//4qNANJZdutTFpIKeaSyX7EjPZMhewAP2W/g+ExVGr/diM2qbpKvNLb5M/d4nKMJ7AC2HLfzpmb2q5iOqCCk4tySbIYrhq6mBa7jMSb3IbLeT3kR0cYHCx41odFuiL6BhaUVvsnccCMpFxrJRI1gfqpGcraRwYUAZaSNHYoYQO1P9IzYP5/xA3kEXmTm/L/z0xc4A3bzibdGFwKR0jsJYI4CTu2jAvTj/HVWmcGl31V9XVDbzHvvdH27uA+cK3RzWt7W0JfcLSnnZW92sPTDeTEim3aUKpe7uK1W6QD7QR5UH5xCRvPxA1gQXtyWzwJ5uFfw== ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=fail (sender ip is 157.254.237.35) smtp.rcpttodomain=designerliving.com smtp.mailfrom=saudades.at; dmarc=none action=none header.from=saudades.at; dkim=none (message not signed); arc=none (0) Received: from AM0PR02CA0127.eurprd02.prod.outlook.com (2603:10a6:20b:28c::24) by AM7P190MB0693.EURP190.PROD.OUTLOOK.COM (2603:10a6:20b:118::7) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9160.11; Fri, 26 Sep 2025 00:20:50 +0000 Received: from AMS1EPF0000004A.eurprd04.prod.outlook.com (2603:10a6:20b:28c:cafe::a8) by AM0PR02CA0127.outlook.office365.com (2603:10a6:20b:28c::24) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9160.10 via Frontend Transport; Fri, 26 Sep 2025 00:20:50 +0000 X-MS-Exchange-Authentication-Results: spf=fail (sender IP is 157.254.237.35) smtp.mailfrom=saudades.at; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=saudades.at; Received-SPF: Fail (protection.outlook.com: domain of saudades.at does not designate 157.254.237.35 as permitted sender) receiver=protection.outlook.com; client-ip=157.254.237.35; helo=[127.0.0.1]; Received: from [127.0.0.1] (157.254.237.35) by AMS1EPF0000004A.mail.protection.outlook.com (10.167.16.134) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9160.9 via Frontend Transport; Fri, 26 Sep 2025 00:20:49 +0000 Content-Type: text/html; charset="utf-8" From: Document360 To: Subject: FiIes Awaiting Review (Ref ID: Designerliving; NIN: 9/25/2025; Amendment to Agreement; A1Q/#zS0#/7670dafd69a9d0bc88be51957a6243f28cc1d45e) Message-ID: <52273695-7519-5abf-420f-87eafe60b440@saudades.at> Content-Transfer-Encoding: quoted-printable Date: Fri, 26 Sep 2025 00:20:49 +0000 Return-Path: jakob@saudades.at X-EOPAttributedMessage: 1 X-MS-TrafficTypeDiagnostic: AMS1EPF0000004A:EE_|AM7P190MB0693:EE_|SA2PEPF00003F66:EE_|CO6PR06MB7490:EE_|BLAPR06MB6834:EE_ X-MS-Office365-Filtering-Correlation-Id: b86e127a-fa38-491b-ea6f-08ddfc928e1f X-MS-Exchange-SenderADCheck: 1 X-MS-Exchange-AntiSpam-Relay: 0 X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|231020011799012|1800799024|82310400026|376014|36860700013|34020700016|8096899003|4076899003|19033499003|7053199007|13003099007|24112699015; X-Microsoft-Antispam-Message-Info-Original: =?utf-8?B?bGVMOEoxd1g5ajgzNXd1cTJnUVVBeFYwUXRVVS9UeWFVbENPdHNnTHQ4dkpS?= =?utf-8?B?M0YxTUlIY2NXbFFRWmhnOXFXc3MwVm5qT1k5eTRFdDZmWENNRThhdWFibW96?= =?utf-8?B?QmQ0aWZFdmxwY2NyM1hxR081bEg4S2lXRUd5Q29wcE9lN1orUHFvM1A3elho?= =?utf-8?B?UlhCYjcvV3YzSXIrc1FXaFJtejlXUk9nb2JpdVNZRFFUMy9CbG51c1hDOE16?= =?utf-8?B?VjM2cndkUEdFWFdmSUtJVTU0Y0FxKytGNUorNEtBQUlyR3RZTG5TU2RwblVC?= =?utf-8?B?ZDFjS2lMaG5GVnZhWEhkTFAzT05acURoWElqZ0NmZDFQb3NiOGx4TExiRmd1?= =?utf-8?B?d2xkakJuVmZ4VXNDU0tXMGNLYmVUMlpKVHlaa0NsT3Y0MmdCNFlpL0J6c056?= =?utf-8?B?NXVVQ0RIWDErWTg3WmNCL0lLZlhxejU2d24yejVBYlBIaHdtbHJyY1NTdWtI?= =?utf-8?B?YnhxRFNKS2ZySm5ZckJjNk43U2xaaUp1MllIZFpzbGQydlBHVFB1MVJKNUFw?= =?utf-8?B?Z29zdWVLblQ4c0JBbzUzbnNCOGxsT0xRSGd3Y3NSMWs0OFdjU2NxTWs3TDR6?= =?utf-8?B?S2hTcEJndU1YY0locXkwTkh5WUpXbG80T0duQ0R6empwU2F2S3p5VnlwMkRk?= =?utf-8?B?MC90VDFXVWpLdFdycHRGbEh5QnAvOUQra0ZnOURYSlI1cVVtRHdQYUtib3No?= =?utf-8?B?dEJjeUFBRS9lbGpCRVVWSFRkbFRuL0VGNkZ4MFhPLzllK0p2eVV1cTRhdjAy?= =?utf-8?B?YlRQaFFMYVFVM0JVZEVhKzBlRTBYMDFYaWlkRTE3OG1UYmVVeEJZNVRVLzd6?= =?utf-8?B?cGNyNjNkUncxbnRUSTZHWUNYdEQ2VmtCM0tFRStxZlFIaUlCTVNDNDdLOEp5?= =?utf-8?B?NFVHbStNL0dpUndZaEtNeC9UY1Yyb0hudDJWQTlLb2E0S0ZOTStHQ2FURzc3?= =?utf-8?B?VitDNE1lWjNaQjNSU1gyT04zL3dsZDVVdDBlK0hVL2JTZGhlR2xyMENnZWxQ?= =?utf-8?B?QlRmTjhhcVpmR3YrWHVpSnN4VEk4Z0F1K21hVWlQZkNJV2Jxa2Rtd1E5Tzhn?= =?utf-8?B?WjFTWUkyNE1DVGNWTk5PcFhSSm0rU21seE9IMUI4dWxXbXppa3VnRC9BT2pL?= =?utf-8?B?a3Y3VE14TkFoYmpxZmc2WkZCRGtqdHNMWUVQWElwYVhlUjRjRmZiMXdhVGFa?= =?utf-8?B?ZXVOM1JUSEhMSzIycjYrWkNXc0RrYkN4b0YwTHI3SFhVNVluMmgyUWZTWG5D?= =?utf-8?B?cytpSDk1bEZRTi9uZ2RZY0VEZEdpamZjZmNuWHdTS3RsVUFWaUJyWURjdWE4?= =?utf-8?B?R0RaR0htUUVjNWhIc1l3T3VlS01BOVVPcXhVMmlCZGxWUUl1OUFKQ1NVTmJ3?= =?utf-8?B?R3NzelFxb1FiTHh1QS9BUEZsUXRBMzhkbmNBdVRpUnB0U1BNWVJMZkFLRFh3?= =?utf-8?B?cDNleHBSdmp5M1ZJbm1xWXdRQ3pqVHJWUUV5RjdLL2JKd2RBMUo1Y2Nsemsz?= =?utf-8?B?SlliUTBIa00vMXFZT0Z0NTMzU3RCcHpZaTdueVFoQm5CZDRFOGp3cDA4NFUw?= =?utf-8?B?MnhRMm9xSHNvb0ZEYUlUd2UwMWxTdWVkdGRaUFZrZWdweXhYdFp4RTBETmtQ?= =?utf-8?B?N3paQmxMclFINEtrNEtiVkw0cFZmUFJhdXVxcTR0OG9ENnNSa2xUSUcwd0lE?= =?utf-8?B?dm91NnFKSzRPNjlxNWloVWpFZ3IzMEs2akVBamgwRHp3cEFJWjdTZzFoUHhF?= =?utf-8?B?dklyNmRUODQxamFzelVmaHZKV3pKK3FpY0RHcXJ2QjFONXV4V21JQ2U0YmJI?= =?utf-8?B?cWJ1WFBmUHVFQ1Ftby93aHpJL2JiUUlYMm9pSXFUWE1zUGNCcURJOXhjYVNR?= =?utf-8?B?Q2I2Qllqa0NnWnpXK2tjclFLTmluYWt3Q0gySkdUL2xUc2R0RnVJVDZSZzZ2?= =?utf-8?B?OVpmSXM1b2pyQ0VyU01qV2NYWjhlMnUrdE55bUY4SFpyQmRVeDRxZTZCcjUy?= =?utf-8?B?dW91RHF6bXlRVno2VlJDREFSQnhkUEd0UE5FQnU1OVE2Ulk1SXFlWElaTk1B?= =?utf-8?B?MWF3TjF6VmgxS2ZGaW4ybVlpV0N1bHlQZ0Irdz09?= X-Forefront-Antispam-Report-Untrusted: CIP:157.254.237.35;CTRY:US;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:[127.0.0.1];PTR:InfoDomainNonexistent;CAT:NONE;SFS:(13230040)(231020011799012)(1800799024)(82310400026)(376014)(36860700013)(34020700016)(8096899003)(4076899003)(19033499003)(7053199007)(13003099007)(24112699015);DIR:OUT;SFP:1102; X-MS-Exchange-Transport-CrossTenantHeadersStamped: AM7P190MB0693 X-MS-Exchange-Organization-ExpirationStartTime: 26 Sep 2025 00:20:53.6359 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: b86e127a-fa38-491b-ea6f-08ddfc928e1f X-EOPTenantAttributedMessage: 5507cbd0-db12-4d17-a196-85902bba4364:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-Exchange-Transport-CrossTenantHeadersStripped: SA2PEPF00003F66.namprd04.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersPromoted: SA2PEPF00003F66.namprd04.prod.outlook.com X-MS-PublicTrafficType: Email X-MS-Exchange-Organization-AuthSource: SA2PEPF00003F66.namprd04.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id-Prvs: b0e8a12a-3ac7-431c-c344-08ddfc928c17 X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|231020011799012|240411011799012|12062699021|5073199012|4073199012|35042699022|8096899003|4076899003|7053199007|13003099007|20103199012|8052699015|24112699015; X-Forefront-Antispam-Report: CIP:2a01:111:f403:c201::3;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:AS8PR04CU009.outbound.protection.outlook.com;PTR:mail-westeuropeazlp170110003.outbound.protection.outlook.com;CAT:NONE;SFS:(13230040)(231020011799012)(240411011799012)(12062699021)(5073199012)(4073199012)(35042699022)(8096899003)(4076899003)(7053199007)(13003099007)(20103199012)(8052699015)(24112699015);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 26 Sep 2025 00:20:53.1934 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: b86e127a-fa38-491b-ea6f-08ddfc928e1f X-MS-Exchange-CrossTenant-Id: 5507cbd0-db12-4d17-a196-85902bba4364 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=31078804-294d-4796-9221-dde04fb02afe;Ip=[157.254.237.35];Helo=[[127.0.0.1]] X-MS-Exchange-CrossTenant-AuthSource: SA2PEPF00003F66.namprd04.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: CO6PR06MB7490 X-MS-Exchange-Transport-EndToEndLatency: 00:02:07.0633853 X-MS-Exchange-Processed-By-BccFoldering: 15.20.9137.014 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710137)(4712097)(4999163)(920097)(930097)(140003); X-Microsoft-Antispam-Message-Info: =?utf-8?B?ZkFIVFViY20vTjdkTktsUmtZWFh3RDBTeFVrQWpiY2VwdzBRQTNYY1ZMZGUx?= =?utf-8?B?NHpuTmQ4a3loVE5mWGJxaGdqS1R0cmYrZm5LRmVMcE1WdTl5RVlSNlpTejVn?= =?utf-8?B?eTdPLzU3dlYvZlJ4Um9Ecis4T01Lb29CdkRyYjFTNHF3bzc4WDk1SzVmWERF?= =?utf-8?B?MGtNUC9MdnJRdWJFRmVrM09BRmJucE9wajBLUU9zU2s4N0prckp4Szhvb09F?= =?utf-8?B?MzlxYmN2dk54aWFkUnNmSmU1R1B1eHJGSENobGNKR0QwNEdPNGNDaEZKMTY3?= =?utf-8?B?blArTUxueGZ6UEswNEtBRFEvK0E1SDJkUzV6OFcyZkdIbjVPeVlZL3gyOEJu?= =?utf-8?B?Rk83ckZuNkJIV1NpL28wOGpVZERNaThRZUh0TDdJbi8vQ28xUklkL0Mwd1R6?= =?utf-8?B?TzNrYm1CWDNYOFlac2FBQjZGbjB4RlV4VEN3czFiRWRTQ3dwdWluQ2dCS3NV?= =?utf-8?B?cVdWR2VPcXNNZC9weXQ3dzJiRFNKNzNTSFBKRk4ySlphS29kdCt4Zi9ieFpy?= =?utf-8?B?NFROTFZpZldhbHF1SHAzQkNQYWhZc2g0UzJFejBYY1hDQ09SZGY0MG5WOW5R?= =?utf-8?B?YXU4d3cxcGlUTEFxK2FZMFNQTmVoVXBvaGJpaDdQK29zdWVvSHFoSUp2TXc3?= =?utf-8?B?RDhndml1Y3hLMUM5YlRIK1hOdVpXWjlhazB2SDhQSThMRlJ4WFArcUkzc0xy?= =?utf-8?B?cGRKUElPZ24wZXpHeGN4UWR4QkNEU21HUGl5aTUyN2FrZWtLMVdSdFYxako4?= =?utf-8?B?SDNzRUw5VWJHaWxZcVJLdEx2OWxYTXpRRUNrMzBiOXdxRHpDMWQxMGVBclNh?= =?utf-8?B?L1ZDWVFPY0ZxMWdvMjB6QS9Xd0szTmRXbEVGemVNWXZRTStHSXRXNUEySEpG?= =?utf-8?B?U3A2R3Z0QlFtREF0QkxOMFJHVjIybzNiL1FNOHhpWGt3alFNdGg5UGlUTmFj?= =?utf-8?B?d3R4T2FzdFVjTlgyQXJ5bnZVZ0lZbHM2Z0xCSVFkcDB1Wk5GQ0h6bnhBOHdu?= =?utf-8?B?cHFXZVV5YXZXSHM3SmtFaXozd3FNbndyVFJ3QlU1SzNocEY1M3Q0WmhlR2s0?= =?utf-8?B?MmpuMTRHQ3BKYitLWlp2NFVNclV1T3hEelJrVDZvR2FCN2dDQzBmcEt1S2hW?= =?utf-8?B?SUVQNlJwcnkrbVlzVkg0U1BvbVZ2U1d5aHQ1Y2Yza3paNnRXZXJ4ZmwxWEV3?= =?utf-8?B?T2QrRXNOQWg1MUJOQzJ6VURLUzNra0NEUUcveGYzL1pObS8xclVHN01lei9U?= =?utf-8?B?OFBoaWRXaWIxYm9HNks4Mm9iaEI3emRnZDNRcmx1UG9vb1Q4djVpU2c5anV0?= =?utf-8?B?WWF0NkRSdWVJYnVUNUM2VnU3TGdHY0EvdUFBdmpHdTNqYy8rTmFZY1JFeURj?= =?utf-8?B?Z1lEcEdZWWpRUjBYNnkrMnZuTjB1NFVSU3lzclNLQXhGSEpOYUw2Z3Rsdisw?= =?utf-8?B?ZUpxMzBuTVpVa2o1aTl1ellIQkdWNmowd05FNDFpS2FQeit5RzN3MDdRcFFs?= =?utf-8?B?SEdRYVMrd3BQYzZTZEQ5UlJiNmxzc0s2K25PazZMK0gzZ1ZVdTJEVUtub3g3?= =?utf-8?B?YTBCNjBERTJvT1RjQmpvSHdYWWdTUU9aZnBNVW02bXBtMGRlVXNnMHBxMVdh?= =?utf-8?B?N3QrNlk2Z09Eb1BsTU9RS2tHV3JkcWJkTUNpdGR4cTNMRGQ4di9VZWwzSnZv?= =?utf-8?B?ZWZVcHB4dnhBbEdwckZyVW4yaXpsN2E4Rm5tMWI0UU1FUWppc1lsTnRVazgv?= =?utf-8?B?ekdIOFp4Nm1QZGlPYzlGVnVXNm9rZjh1alBTc0FOZHV2cTF5eXp2YkpLOHY2?= =?utf-8?B?L0FwT2tVdG5YYXoyWnRJSDIrYk5LaFBXZUF2blEzTUx6S3pvVWJVaW9aSzVo?= =?utf-8?B?cGQxOTJCSzhwVUZ3WWhuWVJZWUpMemdJNGJqWVdTWjU3L1FsR0prVjNkYVNk?= =?utf-8?B?dk1JL29xbHU5bUo5WEk0Q1VSclpMOWZzZ1ZsSHBQQ2dUdEhkY2R5VHYxZG4y?= =?utf-8?B?dUowTEp3OEdRRmw2VnBlWDJWSWcwL0FsNDRIQ2Uxc3QvakgxbUtmU2FrT1FO?= =?utf-8?B?d1FuckZVZGdNL1dndmR0ZzlQbUpLYmYvSzNYVUpFbjl1eFJobFdCME5VNEtZ?= =?utf-8?B?YkhmYzJhU3hqQWNmY2xMNC9sVGptbVZ6Z1YvV0pEYlZpaEZ4WUhDVGVrbnll?= =?utf-8?B?eDVoeFpMa2lTOW5oNEZxdE5xTmVIcU00aTBQK1dod3A3TXdoaCtPTVJjeWFn?= =?utf-8?B?cFZyNkVYc1d3YXM3ZWQ0dHE1MldMeXlpVWhXdmJLYmxhT2VQUG55RUl5RHdG?= =?utf-8?B?QlN6eWE0ZlVHN0Q1c2tIZE1vcG51VDFRMnBudGkvMnRMVWsyeThVRmUrZnZt?= =?utf-8?B?WkpLVGRZSWVpeXprV2NHTWpXbEdINU0wZE1BZEJBU2V4Uy9ERktIeFVnVkRP?= =?utf-8?B?YVYwWTVhZFJtRFhzN2hrdnY0emVsTy8veTR2Tm5EdGVxY0pudzhzWVRkUGpr?= =?utf-8?B?bHFVS3BvOE5kRTJTeGxxV0p0UVhzQnF5ZGlBakFuV2VLajFzNTVaZkNPQmJx?= =?utf-8?B?aGM0MEhZMHRkbXlNNWdsYTlqOFZwYzBvMkF1RXVtU2FQWFpLUWhsZktjRnJX?= =?utf-8?B?UkdHdXhGR0NQMjEzdTFwZEIwOVo3OWdaK2hqY2hleEU4WTNFeGNCSXVnNWNz?= =?utf-8?B?NEdvUHY5M2h3YS9wL2V1aDI4M0hhK2pWU1hGUWFUSTNvQ2dpYkZZVTE3TGVX?= =?utf-8?B?TGNZNHl0b1hVOU5kb081QUxlVzNhenlRRkFDNFpNS0FuMU5lN0dDNDdyalpL?= =?utf-8?B?Z2RjL3dqL2tZcWtISUNhS3A1aCtoRnNVcjA0R1NUQXlPOEZiZ3RJdzBQUVRD?= =?utf-8?B?TDdiRlY4VjJwRGFHR2grODRsQXJmeUU2N3VNbFZTa1d5b1ZBTjgxdFRYNnlp?= =?utf-8?B?ZUVQSjdXUkY1bFhvaU1IN2ZpQXJpTG9zZHNKS0RVMi9nZE5zYWVQeWIwT2VF?= =?utf-8?B?NFZsRHF2UzMyQjgxREJaNGlRc0t5MHZzdytjb2g1MklwRGp4NkozVC84UTFZ?= =?utf-8?B?aG5pWEc2UmlnREtPMU9vN0t6aFQrOFNDSVlnSVB0ZldqaUJ2SWlkOFJBUEp3?= =?utf-8?B?bjBjU0gvb2dqNEt6bnVWZXM2YmJOcUtOZFF5L3BhS09YOTJtaXpZRFBIWlRy?= =?utf-8?B?eG1NbUtiUXNxWjhBN2h2R2NvNzRPd2FJMCsyNEsxY1BvdUh1ZHMxRFVCTWIr?= =?utf-8?B?L0ZjNkIxQTNnc0ZmanZwc1NNaFE4NGpjR3dhb2lQWGI4ajkrUU05TU9UMHpT?= =?utf-8?B?aHFHVysxZW9PK1NacXJJTWU0RnVSVFdxQW56dHNyUk1BaVJEUnN2WWxhOXc3?= =?utf-8?B?RHJrSGM5NmUwbEFwVnFtT2NvOHlYTXlLS3ZSd2hvQlF3V2dWNlkxdEMxVUl3?= =?utf-8?B?ZVZPMjhCdEcyTjdwcUIweTFyaEFrN1AwTm9KQ05xcmhlandQZEx3UFFDTTJP?= =?utf-8?B?c2dWcmtHcVBZaURMVWlXWksyZTN2bHVKU1A1T1prYVRXQnR4UjZiTkwyVXhU?= =?utf-8?B?UU1HSXB5Q3labFhqbEtLWjdiQnFmWll0dllJT1l6TmhCYk5uYjZjYnRGNzlB?= =?utf-8?B?bGJSSlRSS3MxZVozdEEva2xoSG5ibkhOVythbHY4SUtXemVESUdWSkx3Y1p2?= =?utf-8?B?OU9DVm1TRFhOZjRPMjkxSzl0NjlNUU55MEtwOWg0aCtpYVE3KzNrN04zTjR5?= =?utf-8?B?aGpnbEN4N3VoM0Y0UVJxck9rdFZQMG9VZ0xTZFRacFNOV285OTgxaE54VWV1?= =?utf-8?Q?XceL1Nzi6cbkoSdqnYv0N1BL5o?= MIME-Version: 1.0

DocuSign


Your document is ready to be reviewed = and sign

 

REVIEW DOCUMENT

Please review and sign. Document can only be viewed by=20 info@designerliving.com

Thank you for choosing DocuSign.

 

 
Confidential information intended only for the use of the individual o= r entity named above. If you have received this as error, please notify the= sender immediately and delete from your email. Any unauthorized disclosure= , copying, distribution, or use of the information contained in this fax is= strictly prohibited.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hi Catherine, Do you know if we received this final= report? Thanks so much. Best, Marty

 

From: Marty <mburke@cysteticmedicines.com&= gt;
Date: Tuesday, September 16, 2025 at 6:51=E2=80=AFAM
To= : Beth Shapiro Lavin <beth@emilysentourage.org>, Catherine Pelc &= lt;cpelc@devprobiopharma.com>, Daniele Tompkins <dtompkins@devprobiop= harma.com>
Cc: Catherine Strader <cstrader@synergymedicines= .com>
Subject: Re: Emily's Entourage Final Report for cystetic= Medicines

&nbs= p;

H= i Beth, Thanks so much for your email and sorry for the delay in responding= . And thanks so much again for all your tremendous partnership on this stud= y.  We have finished our study, so yes, please go ahead and remove the= landing page. Sorry I am travelling this week, but I will reach out to Jon= SImansky about the payment, and I will also be back in touch soon regardin= g the final report. Thanks again. Best, Marty

 

From: Beth Shapiro Lavin <beth@e= milysentourage.org>
Date: Tuesday, September 9, 2025 at 12:36= =E2=80=AFPM
To: Catherine Pelc <cpelc@devprobiopharma.com>,= Daniele Tompkins <dtompkins@devprobiopharma.com>, Marty <mburke@c= ysteticmedicines.com>
Subject: Re: Emily's Entourage Final Rep= ort for cystetic Medicines

 

Hi Marty, Cat= hy and Daniele, 

Since I hav= en=E2=80=99t received a response, I plan to remove the landin= g page for the cystetic study in Australia from EE's Clinical Trial Con= nect platform this week. If you=E2=80=99d like it to remain active, please = let me know.

I also wanted to check in again on EE=E2=80=99s final p= ayment -- hopefully it=E2=80=99s already in process, but if you need anythi= ng from me to help move it forward, I=E2=80=99d be glad to assist.

 

Thanks,

Beth 

 

On Thu, Aug 28, 2025 at 4:56=E2=80=AFPM Beth S= hapiro Lavin <beth@emilysentourage.org> wrote:

Hi Marty, Cathy and Danielle, 

I wanted to follow up to confi= rm you were able to view the final report and to see if there are any = questions as we close things out.

Additionally, please let me know w= hether you=E2=80=99d like us to keep the landing page active or take it dow= n.

I also sent the final invoice to Jonathan Simansky <jsimansky@deerfield.com<= /a>> but have not yet received a response, so I=E2=80=99d appreciat= e it if you could confirm that it reached the right place.

Thank you= again for your partnership,

Hi Marty, Cathy, and Daniele,= =

I=E2=80=99m pleased to share the final report on Emil= y's Entourage's data registry and recruiting services for cystetic Medicine= s in support of the CM001001 Study. I=E2=80=99d be happy to schedule a call= to walk through the report together and debrief, if that would be helpful.= Please let me know if your team has any questions.

&nb= sp;

It=E2=80=99s been a pleasure working = with cystetic and DevPro to support this study, especially as we piloted ou= r international outreach in Australia. We=E2=80=99ve truly valued having yo= u as a partner and collaborator. As we close out this phase of our work, he= re are the remaining items:

 

  1. Final Invoice: I=E2=80=99ll forward the final invoice for our ser= vices under this engagement.

 

2.    Landing Page: If recr= uitment is still ongoing, we can keep the landing page li= ve for passive recruitment. I can check in monthly for updates. I can also = notify you of any interest we receive, and we are happy to make any referra= ls if/where possible. Please let me know if you=E2=80=99d like us to kee= p it active at this time or archive it (take it down) at this time. 

 

3.    Share-Back Reminder: Transparency and sharing informa= tion back to our community is extremely important to EE. As outlined in our= contract, Section 8A. =E2=80=9CThe Company agrees that, if the results = of the Study are published, a summary thereof shall be made available to Em= ily=E2=80=99s Entourage, to the extent permitted by the Company=E2=80=99s c= opyright ownership, for dissemination within thirty (30) days of publicatio= n.=E2=80=9D We understand this may be far in the future, but if/when re= sults are available, please email the summary to me and copy admin@emilysentourage.org<= /a> so we can ensure timely review and sharing with our community.

 

If there ar= e future phases of this study or other projects that we can support using E= E=E2=80=99s Clinical Trial Connect database, we would be honored to work to= gether again.

 

Thanks s= o much,

Beth

<= o:p> 

--

<= p class=3D"MsoNormal">

 

--

3D"Image

Fast Breakthroughs for Cystic Fibrosis!<= /b>

 

=  

No goods or services pro= vided.  Contributions are tax-deductible to the full extent of th= e law (Tax ID #45-3768161)


 

--

No goods or services provided.  Contributions are tax-dedu= ctible to the full extent of the law (Tax ID #45-3768161)